# Elantas Beck India (NSE: ELANTAS) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/ELANTAS · Pivot · prices to 22 Oct 2026

Elantas Beck India (NSE: ELANTAS) closed at ₹13,384.00 on 22 Oct 2026, up 1.12% on the day. With a market capitalisation of ₹10,610 Cr, it ranks 540th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Chemicals sector; its industry is Specialty Chemicals.

At its last close the stock traded at 72.7× trailing earnings, against a return on equity of 14.7% in FY26. Its 52-week range is ₹8,900.00 (18 May 2026) to ₹15,150.00 (22 Sep 2026); the last close is 11.7% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹283 Cr (+35.0% year on year) and net profit ₹71 Cr (+80.4%), on a standalone basis. Promoters held 75.00% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹13,384.00 |
| Market cap | ₹10,610 Cr |
| P/E (trailing) | 72.7 |
| ROE | 14.7% (FY26) |
| ROCE | 19.1% (FY26) |
| Debt to equity | 0 |
| 52-week high | ₹15,150.00 (22 Sep 2026) |
| 52-week low | ₹8,900.00 (18 May 2026) |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹283 Cr | +35.0% | ₹71 Cr | +80.4% | ₹89.39 |
| Q4 FY26 | ₹222 Cr | +7.8% | ₹31 Cr | −5.4% | ₹39.21 |
| Q3 FY26 | ₹215 Cr | +9.3% | ₹39 Cr | +32.4% | ₹49.66 |
| Q2 FY26 | ₹217 Cr | +18.0% | ₹36 Cr | +16.7% | ₹45.74 |
| Q1 FY26 | ₹210 Cr | +9.7% | ₹39 Cr | −6.1% | ₹49.56 |
| Q4 FY25 | ₹206 Cr | +16.7% | ₹33 Cr | −10.9% | ₹41.46 |
| Q3 FY25 | ₹197 Cr | +13.3% | ₹30 Cr | −19.6% | ₹37.52 |
| Q2 FY25 | ₹184 Cr | +12.4% | ₹31 Cr | −10.8% | ₹39.19 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY26 | ₹848 Cr | ₹148 Cr |
| FY25 | ₹749 Cr | ₹140 Cr |
| FY24 | ₹680 Cr | ₹137 Cr |
| FY23 | ₹645 Cr | ₹98 Cr |
| FY22 | ₹522 Cr | ₹67 Cr |
| FY21 | ₹383 Cr | ₹62 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 75.00%
- Foreign institutions: 0.05%
- Domestic institutions: 12.28%
- Non-institutions: 12.67%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Privi Speciality Chemicals](https://app.pivotnow.in/stock/PRIVISCL) | ₹3,375.00 | ₹12,861 Cr | 40.2 | 16.9% |
| [Anupam Rasayan India](https://app.pivotnow.in/stock/ANURAS) | ₹1,094.90 | ₹12,561 Cr | 71.1 | 5.1% |
| [PCBL Chemical](https://app.pivotnow.in/stock/PCBL) | ₹293.00 | ₹11,528 Cr | 57 | — |
| [Vinati Organics](https://app.pivotnow.in/stock/VINATIORGA) | ₹1,097.60 | ₹11,378 Cr | 25.7 | — |
| [Alkyl Amines Chemicals](https://app.pivotnow.in/stock/ALKYLAMINE) | ₹1,732.40 | ₹8,861 Cr | 49.2 | — |
| [Sudarshan Chemical Industries](https://app.pivotnow.in/stock/SUDARSCHEM) | ₹1,098.60 | ₹8,638 Cr | 391 | — |

## Questions and answers

### What is the share price of Elantas Beck India today?

Elantas Beck India (NSE: ELANTAS) last closed at ₹13,384.00 on 22 Oct 2026. Its 52-week high is ₹15,150.00 and its 52-week low is ₹8,900.00.

### What is the market cap of Elantas Beck India?

Elantas Beck India's market capitalisation is ₹10,610 Cr (₹10,610 Cr) at the 22 Oct 2026 close, ranking 540th among the NSE companies Pivot tracks.

### What is the P/E ratio of Elantas Beck India?

Elantas Beck India trades at a trailing P/E of 72.7. The median P/E of the 6 closest Chemicals peers by market cap is 57.

### What is the ROE and ROCE of Elantas Beck India?

Return on equity was 14.7% in FY26 and return on capital employed was 19.1% in FY26 (standalone figures).

### Is Elantas Beck India a debt-free company?

Elantas Beck India is close to debt-free: its debt-to-equity ratio was 0 in FY26.

### What were Elantas Beck India's latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), Elantas Beck India reported revenue of ₹283 Cr, +35.0% year on year, and net profit of ₹71 Cr, +80.4% year on year.

### What is the shareholding pattern of Elantas Beck India?

As of 30 Jun 2026: promoters 75.00%, foreign institutions 0.05%, domestic institutions 12.28%, non-institutions 12.67%.

### Who are Elantas Beck India's competitors?

The listed Chemicals companies closest to Elantas Beck India by market cap are Privi Speciality Chemicals, Anupam Rasayan India, PCBL Chemical, Vinati Organics, Alkyl Amines Chemicals and Sudarshan Chemical Industries.

### Is Elantas Beck India a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Elantas Beck India's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ELANTAS against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.